Researchers at the ICR co-led a recent study showing that it is possible to reverse drug resistance and slow tumour progression in prostate cancer by targeting myeloid white blood cells. Tumours can ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

Jesse was two years old when he was diagnosed with B-cell acute lymphoblastic leukaemia, a type of blood and bone marrow ...

Researchers have carried out an in-depth analysis of 10,478 cancer genomes across 35 different cancer types, identifying 330 potential cancer-driving genes, 74 of which are newly associated with ...

Image: The Man Van. Credit: The Man Van and The Royal Marsden NHS Foundation Trust. Mobile testing ‘Man Van’ can diagnose ...

Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Video: ICR Chief Executive Kristian Helin gives an overview ...

Image: DNA sequence. Credit: The Institute of Cancer Research, London. A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for one ...

The ICR-CTSU is a CR-UK funded, internationally recognised methodologist led clinical trials unit, providing cancer-focussed clinical trial research expertise. We lead pioneering, efficient, ...

Dr Martin Kaiser’s group aims to design gentler, tailored therapies for patients with multiple myeloma, an immune cell cancer of the bone marrow. I joined the team in December 2020 and I am involved ...

Professor Sebastian Guettler is Deputy Head of the Division of Structural Biology. He studies the precise molecular mechanisms of signalling processes central to cancer stem cell function, with a ...

Professor Rosalind Eeles is searching for genetic variants that increase a person’s risk of prostate cancer and is currently leading clinical trials looking into whether regular screening of men with ...

Professor Clare Isacke aims to identify the processes by which tumour cells recruit non-cancerous cells during metastasis. She has held several senior positions at the ICR, including acting as Interim ...